Cargando…

Toll-like receptor 4 polymorphisms and ankylosing spondylitis

Detalles Bibliográficos
Autores principales:	Adam, R, Gracie, JA, Sturrock, RD
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834166/ http://dx.doi.org/10.1186/ar1696

Ejemplares similares

Immunophenotype and functional characteristics of rheumatoid arthritis derived myeloid dendritic cells and plasmacytoid dendritic cells
por: Jongbloed, S, et al.
Publicado: (2005)

A polymorphism within the Transforming Growth Factor β1 gene is associated with ankylosing spondylitis (AS)
por: McGarry, F, et al.
Publicado: (2002)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Toll like receptor 1 polymorphisms and susceptibility to invasive candidiasis
por: Plantinga, T, et al.
Publicado: (2009)

Intra-rater reliability of the bath ankylosing spondylitis disease activity index (BASDAI) and the bath ankylosing spondylitis functional index (BASFI) in children with spondyloarthritis
por: Batthish, Michelle, et al.
Publicado: (2012)

Genetic Polymorphisms of Toll-like receptors 2 and 9 as Susceptibility Factors for the Development of Ankylosing Spondylitis and Psoriatic Arthritis
por: Oliveira-Toré, Camila F., et al.
Publicado: (2019)

Ankylosing spondylitis: yesterday and today.
por: Spencer, D G, et al.
Publicado: (1980)

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
por: Morales-Lara, M J, et al.
Publicado: (2010)

Role of TRAILR1 and TNFR1A polymorphisms in the susceptibility and pharmacogenetics of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
por: Morales-Lara, M J, et al.
Publicado: (2010)

Expression and function of Toll-like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis
por: Zhang, Jun, et al.
Publicado: (2019)

Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis
por: Baraliakos, X, et al.
Publicado: (2005)

Selective inhibition of Toll-like receptor 4 signaling by the small molecule TAK-242
por: Kawamoto, T, et al.
Publicado: (2006)

P24 Ankylosing spondylitis & uveitis - challenges in management
por: Nowak, Katarzyna, et al.
Publicado: (2021)

PReS-FINAL-2078: Single nucleotide polymorphisms of toll like receptors 2 and 4 in enthesitis related arthritis and oligo and polyarticular juvenile idiopathic arthritis
por: Perica, M, et al.
Publicado: (2013)

Toll-like receptor expression in synovial fibroblasts and normal skin fibroblasts and induction of matrix metallo-proteinase expression by various Toll-like receptor ligands
por: Kyburz, D, et al.
Publicado: (2005)

Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
por: Horneff, G, et al.
Publicado: (2011)

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept
por: Baraliakos, X, et al.
Publicado: (2005)

Toll-Like Receptors are critical in controlling colonic inflammation and cancer
por: Xiao, Hui, et al.
Publicado: (2011)

Toll-like receptor ligands regulate the migratory pattern of leukocytes
por: Nieto, J C, et al.
Publicado: (2010)

Differential Toll-like receptor-dependent collagenase expression in chondrocytes
por: Zhang, Qian, et al.
Publicado: (2007)

Toll-like receptor 2 polymorphism in juvenile dermatomyositis
por: Mathiesen, P, et al.
Publicado: (2011)

Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
por: Baraliakos, X, et al.
Publicado: (2005)

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Comparison of proliferation and differentiation of osteoblasts derived from vertebral body and lamina in patients with thoracolumbar kyphosis secondary to Ankylosing Spondylitis
por: Qian, Bangping, et al.
Publicado: (2015)

Toll-like receptor 4 in phagocytosis of Escherichia coli by endotoxin-activated human neutrophils in whole blood
por: Prokhorenko, I, et al.
Publicado: (2012)

Perivascular adipocytes and signaling through toll-like receptors: role in the pathophysiology of atherosclerosis
por: Benaiges, C, et al.
Publicado: (2010)

Regulation of neutrophil chemotaxis by toll-like receptor 9 is important for sepsis survival
por: Trevelin, SC, et al.
Publicado: (2010)

Gastrin-releasing peptide receptor antagonist induces a protection from lethal sepsis: involvement of toll-like receptor 4 signaling
por: Petronilho, F, et al.
Publicado: (2010)

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
por: Edgson, Lucy, et al.
Publicado: (2010)

Recurrent macrophage activation syndrome since toddler age in a patient with HLA B27 positive juvenile ankylosing spondylitis
por: Lee, Soo Young, et al.
Publicado: (2014)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock
por: Hosaka, Y, et al.
Publicado: (2004)

Ankylosing spondylitis functional and activity indices in clinical practice
por: Popescu, C, et al.
Publicado: (2014)

The expression and function of toll-like receptors (TLRs) in ovarian cancer cell lines
por: Lee, Shin-Wha, et al.
Publicado: (2015)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Induction of hypoxia inducible factor 1α by Toll-like receptors in human dendritic cells
por: Djafarzadeh, S, et al.
Publicado: (2008)

Integrative analysis of long non-coding RNA and messenger RNA expression in toll-like receptor 4-primed mesenchymal stem cells of ankylosing spondylitis
por: Li, Yu-Xi, et al.
Publicado: (2021)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fhbk84850t97bc92ktn75ihuhn